Supriya Lifescience Limited (NSE: SUPRIYA), ISIN INE07RO01027 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SUPRIYA last traded at ₹859.65 (+3.51%), with a 52-week range of ₹545.65 to ₹1085.50 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 68.30%, FIIs 6.19%, DIIs 5.30%, mutual funds 1.29%.
EquiSense Score (ECS): 85/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.